相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Johnson & Johnson Vaccine for COVID-19
Edward H. Livingston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection
Allison M. Owen et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Effect of Recombinant Human Interferon Alpha Nasal Drops to Pre-vent COVID-19 Pneumonia for Medical Staff in an Epidemic Area
Zhongji Meng et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2021)
Innate Immune Evasion by Human Respiratory RNA Viruses
Marjolein Kikkert
JOURNAL OF INNATE IMMUNITY (2020)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
All together to Fight COVID-19
Sara Momtazmanesh et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin
Theoharis C. Theoharides
BIOFACTORS (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients
Pierre Bost et al.
CELL (2020)
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Evangelos J. Giamarellos-Bourboulis et al.
CELL HOST & MICROBE (2020)
Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics
Arun K. Ghosh et al.
CHEMMEDCHEM (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
Francesca Coperchini et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
IL-6: Relevance for immunopathology of SARS-CoV-2
E. O. Gubernatorova et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
Yang Yang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
SARS-CoV-2: a storm is raging
Savannah F. Pedersen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
SARS-CoV-2 productively infects human gut enterocytes
Mart M. Lamers et al.
SCIENCE (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Interferon-α2b Treatment for COVID-19
Qiong Zhou et al.
FRONTIERS IN IMMUNOLOGY (2020)
Bioinformatic analysis and identi fication of single -stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes
Mario Adan Moreno-Eutimio et al.
MICROBES AND INFECTION (2020)
Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury
Yingxia Liu et al.
NATIONAL SCIENCE REVIEW (2020)
Surviving COVID-19: A disease tolerance perspective
Janelle S. Ayres
SCIENCE ADVANCES (2020)
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Mingfeng Liao et al.
NATURE MEDICINE (2020)
A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19
Effat Davoudi-Monfared et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Biomarkers associated with COVID-19 disease progression
Giovanni Ponti et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2020)
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
He-wei Jiang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses
Runhong Zhou et al.
IMMUNITY (2020)
COVID 19: a clue from innate immunity
Domenico Birra et al.
IMMUNOLOGIC RESEARCH (2020)
Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal
Mohammad Sultan Khuroo
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
Jeong Seok Lee et al.
SCIENCE IMMUNOLOGY (2020)
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
Gabriella d'Ettorre et al.
FRONTIERS IN MEDICINE (2020)
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
Spinello Antinori et al.
PHARMACOLOGICAL RESEARCH (2020)
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study
Andrew Ip et al.
PLOS ONE (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes
Ildefonso Sanchez-Cerrillo et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19)
Omalla A. Olwenyi et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
Drug repurposing approach to fight COVID-19
Thakur Uttam Singh et al.
PHARMACOLOGICAL REPORTS (2020)
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Prabhu S. Arunachalam et al.
SCIENCE (2020)
Immune Correlates of COVID-19 Control
Bhawna Poonia et al.
FRONTIERS IN IMMUNOLOGY (2020)
The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing
Gang Xu et al.
CELL DISCOVERY (2020)
COVID-19 Public needs to prep for vaccine side effects
Meredith Wadman
SCIENCE (2020)
IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?
Shubham Atal et al.
PHARMACEUTICAL MEDICINE (2020)
Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence
Beth Russell et al.
ECANCERMEDICALSCIENCE (2020)
Decoding type I and III interferon signalling during viral infection
Emily Mesev et al.
NATURE MICROBIOLOGY (2019)
Dendritic Cell Accumulation in the Gut and Central Nervous System Is Differentially Dependent on α4 Integrins
Christopher Sie et al.
JOURNAL OF IMMUNOLOGY (2019)
Recent clinical trends in Toll-like receptor targeting therapeutics
Muhammad Ayaz Anwar et al.
MEDICINAL RESEARCH REVIEWS (2019)
MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
Waleed H. Mahallawi et al.
CYTOKINE (2018)
Pattern Recognition Receptors and the Host Cell Death Molecular Machinery
Gustavo P. Amarante-Mendes et al.
FRONTIERS IN IMMUNOLOGY (2018)
Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs
Liang Cheng et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication
Eveline Kindler et al.
PLOS PATHOGENS (2017)
The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the endosome
Carlene Petes et al.
FRONTIERS IN IMMUNOLOGY (2017)
Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: A randomized trial
A. K. Ellis et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2017)
Leukocyte Trafficking to the Small Intestine and Colon
Aida Habtezion et al.
GASTROENTEROLOGY (2016)
SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6
Shih-Wen Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Aryl Hydrocarbon Receptor Interacting Protein Targets IRF7 to Suppress Antiviral Signaling and the Induction of Type I Interferon
Qinjie Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options
Vijayakumar Velu et al.
RETROVIROLOGY (2015)
Mast cells and influenza A virus: association with allergic responses and beyond
Amy C. Graham et al.
FRONTIERS IN IMMUNOLOGY (2015)
Novel drugs targeting Toll-like receptors for antiviral therapy
Mira C. Patel et al.
FUTURE VIROLOGY (2014)
Toll-Like Receptors in Antiviral Innate Immunity
Sandra N. Lester et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes
Hua Nian et al.
BMC INFECTIOUS DISEASES (2012)
Azithromycin distinctively modulates classical activation of human monocytes in vitro
M. Vrancic et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques
Ravi Dyavar Shetty et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The TLR7/8 Agonist CL097 Primes N-Formyl-Methionyl-Leucyl-Phenylalanine-Stimulated NADPH Oxidase Activation in Human Neutrophils: Critical Role of p47phox Phosphorylation and the Proline Isomerase Pin1
Karama Makni-Maalej et al.
JOURNAL OF IMMUNOLOGY (2012)
Structure-Activity Relationships in Human Toll-like Receptor 8-Active 2,3-Diamino-furo[2,3-c]pyridines
Deepak B. Salunke et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Microbial translocation in HIV infection: causes, consequences and treatment opportunities
Netanya G. Sandler et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia
Cheng-Tao Lin et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2012)
Plasmacytoid dendritic cells are recruited to the colorectum and contribute to immune activation during pathogenic SIV infection in rhesus macaques
Suefen Kwa et al.
BLOOD (2011)
Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
Alenka Kuznik et al.
JOURNAL OF IMMUNOLOGY (2011)
Homing of Immune Cells: Role in Homeostasis and Intestinal Inflammation
Ailsa L. Hart et al.
INFLAMMATORY BOWEL DISEASES (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Immunity and immunopathology to viruses: what decides the outcome?
Barry T. Rouse et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Coronaviruses post-SARS: update on replication and pathogenesis
Stanley Perlman et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients
Say Li Kong et al.
VIRUS RESEARCH (2009)
The antiviral activity of toll-like receptor 7 and 7/8 agonists
Richard L. Miller et al.
DRUG NEWS & PERSPECTIVES (2008)
TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells
Tom A. Barr et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Oral resiquimod in chronic HCV infection: Safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies
Paul J. Pockros et al.
JOURNAL OF HEPATOLOGY (2007)
Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon
Luisa Cervantes-Barragan et al.
BLOOD (2007)
Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides
Marion Jurk et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
An interferon-γ-related cytokine storm in SARS patients
KJ Huang et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
F Heil et al.
SCIENCE (2004)
Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells
TM Schaefer et al.
IMMUNOLOGY (2004)
Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome - A preliminary study
MR Loutfy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
分享论文
